Imc Chicago, LLC Sarepta Therapeutics, Inc. Transaction History

Imc Chicago, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$63.15 - $90.42 $959,437 - $1.37 Million	-15,193 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $20,711 - $26,644	268 Added 1.8%	15,193 $1.37 Million
Q3 2021 Nov 05, 2021	BUY	$65.97 - $92.48 $170,202 - $238,598	2,580 Added 20.9%	14,925 $1.38 Million
Q2 2021 Aug 06, 2021	BUY	$69.38 - $86.75 $40,032 - $50,054	577 Added 4.9%	12,345 $960,000
Q1 2021 May 14, 2021	BUY	$72.25 - $168.95 $850,238 - $1.99 Million	11,768 New	11,768 $877,000
Q2 2019 Aug 15, 2019	SELL	$112.21 - $151.95 $1.33 Million - $1.8 Million	-11,864 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $1.27 Million - $1.8 Million	11,864 New	11,864 $1.41 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.